openPR Logo
Press release

Diagnostic Biomarker Market Growth, Share, Trends and Overview 2023-2029

02-17-2023 07:08 PM CET | Health & Medicine

Press release from: Orion Market Research

Diagnostic Biomarker Market Growth, Share, Trends and Overview

The global diagnostic biomarker market is anticipated to grow at a considerable CAGR of 12.9% during the forecast period. The rising pervasiveness of chronic diseases is one of the prime factors affecting and driving the market. Chronic diseases include such as heart disease, cancer, diabetes, stroke, and arthritis among others that are affecting people across the globe. Rise in chronic diseases is also increasing the requirement and generating the need for research and development of diagnostic biomarker.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/diagnostic-biomarker-market

The key players operating in the global diagnostic biomarker market had been adopting strategy such as new launches to gain major market share. For instance, in April 2021, one of the global medical technology company Siemens Healthineers had undergone through a strategic agreement with a company providing proteomics solutions for dry discovery and development name as biognosys. With the support of this agreement both the companies would be offering customers with novel biomarkers with the means of HRM technology.

Market Coverage

• The market number available for - 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
o By Application
o By Diagnostic Technique
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Abbott, F. Hoffmann-La Roche Ltd, Merck KgaA, SIGNOSIS INC., and QIAGEN

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Diagnostic Biomarker Market - Segmentation

By Application

• Oncology
• Cardiology
• Neurology
• Nephrology
• Other

By Diagnostic Technique

• Elisa
• Colorimetric Assay
• Liquid Chromatography-Mass Spectrometry
• Particle-Enhanced Turbidimetric Immunoassay
• Other

By End-User

• Hospitals & Diagnostic Labs
• Research Centers

A full report of Diagnostic Biomarker Market is available at: https://www.omrglobal.com/industry-reports/diagnostic-biomarker-market

Diagnostic Biomarker Market- Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Abbott
• Astellas Pharma Inc.
• Astute Medical, In
• Agendia.
• Avacta Life Sciences Ltd.
• BANYAN BIOMARKERS
• Bayer AG
• Beckman Coulter, Inc
• Biodesix
• Biomarker Technologies, Inc.
• bioMerieux SA
• BioPorto A/S

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit More Report at

https://www.asiatimeskorea.com/press-release/t-%eb%a6%bc%ed%94%84%ea%b5%ac-%ed%99%9c%ec%84%b1%ed%99%94-%ed%95%ad%ec%9b%90-cd80-%ec%8b%9c%ec%9e%a5-%eb%8f%99%ed%96%a5-%ec%97%b0%ea%b5%ac-%eb%b3%b4%ea%b3%a0%ec%84%9c-%ec%84%b1%ec%9e%a5-%ea%b8%b0/326646/
https://www.diario-ya.com/regionales/%e9%85%aa%e6%b0%a8%e9%85%b8%e8%9b%8b%e7%99%bd%e6%bf%80%e9%85%b6-fyn-%e5%b8%82%e5%9c%ba%e8%b6%8b%e5%8a%bf%e3%80%81%e6%9c%aa%e6%9d%a5%e5%b1%95%e6%9c%9b%e3%80%81covid-19-%e5%bd%b1%e5%93%8d%e5%88%86/389174/
https://sportmsr.com/2029-%d8%a7%d8%aa%d8%ac%d8%a7%d9%87%d8%a7%d8%aa-%d8%b3%d9%88%d9%82-%d8%b9%d9%84%d8%a7%d8%ac-%d8%a7%d9%84%d8%af%d9%88%d8%a7%d9%84%d9%8a-%d8%8c-%d8%aa%d9%82%d8%b1%d9%8a%d8%b1-%d8%a8%d8%ad%d8%ab%d9%8a/
https://monblogapple.com/2023/02/10/tendances-du-marche-des-biomarqueurs-du-cancer-rapport-de-recherche-croissance-opportunites-et-previsions-2023-2029/
https://citytoday-hildesheim.de/index.php/2023/02/10/knochenkrebsdiagnose-und-therapeutika-marktgrose-anteil-branchenwachstum-analyse-und-prognose-2023-2029/

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diagnostic Biomarker Market Growth, Share, Trends and Overview 2023-2029 here

News-ID: 2936868 • Views:

More Releases from Orion Market Research

Healthcare Distribution Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Healthcare Distribution Market Size, Trends, Latest Insights, Analysis and Forec …
Global healthcare distribution market is anticipated to grow at a CAGR of 6.7% during the forecast period (2024-2031). Globally, a considerable increase in the burden of chronic diseases pressuring countries to adopt effective and efficient distribution of healthcare products. Commonly prevailing chronic diseases include heart attacks and strokes, cancer such as breast and colon, diabetes, epilepsy and seizures, obesity, and oral health issues. To learn more about this report request
Prediabetes Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Prediabetes Market Size, Trends, Latest Insights, Analysis and Forecast 2024-203 …
Global prediabetes market is anticipated to grow at a CAGR of 7.2% during the forecast period (2024-2031). A major factor supporting the growth of the market is the increasing product expansion and new drugs in the market. For instance, in January 2024, Novo Nordisk announced the launch of its Wegovy, a GLP-1 analog in the UK. This drug can be prescribed to people with prediabetes and for weight loss purposes.
Rapid Test Market Increasing Demand, Growth Analysis and Future Outlook by 2031
Rapid Test Market Increasing Demand, Growth Analysis and Future Outlook by 2031
The global rapid test market is anticipated to grow at a considerable CAGR of 8.2% during the forecast period (2024-2031). The increasing government initiatives for diagnosing infectious diseases owing to the growing prevalence of infectious diseases and the key developments by the market players. In order to monitor the infection rate of specific pathogens, infection monitoring and surveillance programs have grown over the past few several years. Rapid diagnostic
AI in Patient Engagement Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
AI in Patient Engagement Market Size, Trends, Latest Insights, Analysis and Fore …
Global AI in patient engagement market is anticipated to grow at a CAGR of 21.0 % during the forecast period (2024-2031). AI-powered communication tools support patients by addressing their inquiries, scheduling appointments, and providing information about their health conditions and treatments. These tools enhance patient engagement, improve access to healthcare information, and streamline administrative processes for healthcare providers. Furthermore, AI algorithms analyze large datasets, including electronic health records (EHRs), medical

All 5 Releases


More Releases for Diagnostic

Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects. Tenet Diagnostics got its NABL certification in the fastest time and is
Global Tissue Diagnostic Market 2020 Business Strategies – Roche Diagnostic, A …
The Zion Market Research added a new report “Tissue Diagnostic Market by Product Type (Consumables and Instruments), by Technology (Immunohistochemistry (IHC), in Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining), by Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Others), and by End-users (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends
POC Cardiovascular Diagnostic Market Report 2018: Segmentation by Product (Diagn …
Global POC Cardiovascular Diagnostic market research report provides company profile for F. Hoffmann-La Roche, Siemens, Abbott, Biomerieux, Danaher and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on
Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV
Diagnostic Imaging Services Market Trending Technologies and Company Overview 20 …
Diagnostic Imaging Services market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the